Your browser doesn't support javascript.
loading
Healthcare migration in Italian paediatric haematology-oncology centres belonging to AIEOP.
Rondelli, Roberto; Belotti, Tamara; Masetti, Riccardo; Locatelli, Franco; Massimino, Maura; Biffi, Alessandra; Dufour, Carlo; Fagioli, Franca; Menna, Giuseppe; Biondi, Andrea; Favre, Claudio; Zecca, Marco; Santoro, Nicola; Russo, Giovanna; Perrotta, Silverio; Pession, Andrea; Prete, Arcangelo.
Afiliação
  • Rondelli R; Pediatric Oncology and Hematology Unit "Lalla Seràgnoli, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy. roberto.rondelli@aosp.bo.it.
  • Belotti T; Pediatric Oncology and Hematology Unit "Lalla Seràgnoli, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
  • Masetti R; Pediatric Oncology and Hematology Unit "Lalla Seràgnoli, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
  • Locatelli F; Department of Hematology Oncology and Transfusion Medicine, IRCCS Pediatric Hospital "Bambino Gesù", Rome, Italy.
  • Massimino M; Pediatric Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Biffi A; Pediatric Hematology, Oncology and Stem Cell Transplant Division, Padua University Hospital, Padua, Italy.
  • Dufour C; Department of Pediatric and Hemato-Oncologic Sciences, IRCCS "Istituto Giannina Gaslini", Genoa, Italy.
  • Fagioli F; Paediatric Onco-Haematology Division, Regina Margherita Children's Hospital, City of Health and Science of Turin, Turin, Italy.
  • Menna G; Department of Woman, Child and of General and Specialized Surgery, Pediatric Hematology Unit, Università Degli Studi Della Campania, Naples, Italy.
  • Biondi A; Pediatrics, Fondazione IRCCS San Gerardo Dei Tintori, Monza, Italy.
  • Favre C; School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Zecca M; Department of Pediatric Hematology Oncology, Meyer Children's Hospital Istituto Di Ricovero E Cura a Carattere Scientifico (IRCCS), Florence, Italy.
  • Santoro N; Pediatric Hematology/Oncology, Fondazione Istituto Di Ricerca E Cura a Carattere Scientifico (IRCCS) Policlinico S. Matteo, Pavia, Italy.
  • Russo G; Oncology and Hematology, University Hospital of Policlinic, Bari, Italy.
  • Perrotta S; Department of Clinical and Experimental Medicine, Pediatric Hematology and Oncology Unit, University of Catania, Catania, Italy.
  • Pession A; Department of Women, Children and General and Specialized Surgery, "Luigi Vanvitelli" Università Degli Studi Della Campania, Naples, Italy.
  • Prete A; Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
Ital J Pediatr ; 50(1): 44, 2024 Mar 07.
Article em En | MEDLINE | ID: mdl-38454431
ABSTRACT

BACKGROUND:

In Italy, there is a network of centres headed by the Italian Association of Pediatric Hematology and Oncology (AIEOP) for the diagnosis and treatment of paediatric cancers on almost the entire national territory. Nevertheless, migration of patients in a hospital located in a region different from that of residence is a widespread habit, sometimes motivated by several reasons. The aim of this paper is to assess the impact of migration of children with cancer to AIEOP centres in order to verify their optimal distribution throughout the national territory.

METHODS:

To this purpose, we used information on 41,205 registered cancer cases in the database of Mod.1.01 Registry from AIEOP centres, with age of less than 20 years old at diagnosis, diagnosed from 1988 to 2017. Patients' characteristics were analysed and compared using the X2 or Fisher's exact test or Mann-Whitney test, when appropriate. Survival distributions were estimated using the method of Kaplan and Meier, and the log-rank test was used to examine differences among subgroups.

RESULTS:

Extra-regional migration involved overall 19.5% of cases, ranging from 23.3% (1988-1997) to 16.4% (2008-2017) (p < 0.001). In leukaemias and lymphomas we observed a mean migration of 8.8% overall, lower in the North (1.2%) and Centre (7.8%) compared to the South & Isles (32.3%). In the case of solid tumours, overall migration was 25.7%, with 4.2% in the North, 17.2% in the Centre and 59.6% in the South & Isles. For regions with overall levels of migration higher than the national average, most migration cases opted for AIEOP centres of close or even neighbouring regions. Overall survival at 10 years from diagnosis results 69.9% in migrants vs 78.3% in no migrants (p < 0.001).

CONCLUSIONS:

There is still a certain amount of domestic migration, the causes of which can be easily identified migration motivated by a search for high specialization, migration due to lack of local facilities, or regions in which no AIEOP centres are present, which makes migration obligatory. Better coordination between AIEOP centres could help to reduce so-called avoidable migration, but technical and political choices will have to be considered, with the active participation of sector technicians.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hematologia / Neoplasias Limite: Adolescent / Child / Humans País/Região como assunto: Europa Idioma: En Revista: Ital J Pediatr Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hematologia / Neoplasias Limite: Adolescent / Child / Humans País/Região como assunto: Europa Idioma: En Revista: Ital J Pediatr Ano de publicação: 2024 Tipo de documento: Article